Hughes Report: Second Anniversary

Laura Kyrke-Smith Excerpts

Wednesday 11th February 2026 Westminster Hall

[Sarah Green]

I do agree with my hon. Friend and thank him for his intervention.

[Laura Kyrke-Smith (Aylesbury) (Lab)]

This is about so many different aspects of support. One of the recommendations in the Hughes report that has been drawn to my attention is the one on housing, which is so crucial. My constituent was prescribed sodium valproate during pregnancy. Her son, who is now 25, lives with foetal valproate syndrome, requires 24/7 support, and will do for the rest of his life. My constituent said that even relatively modest adjustments to their home and some specialist equipment could make a real difference, but she has not found any way of getting funding for that. Does the hon. Member agree that housing is also a really important area for us to look at?

[Sarah Green]

I do agree, and I thank the hon. Member for raising it.

I know that many colleagues present have been championing this cause for years. There is a string of parliamentary questions going back to the launch of the report two years ago, asking for progress updates. The Patient Safety Commissioner herself used her statutory powers for the first time, in October last year, to ask for more detailed answers from the Department of Health and Social Care. The responses were published in November and just a few weeks ago in January. We now know that there have been meetings, roundtables and briefings, but no progress on redress. If I am reading between the lines of these responses correctly, it is the dead hand of the Treasury that is the issue.

Before I conclude, I wish to mention Carol. I have shared Carol’s story before, and I return to it today because it lays bare the cost of years of Government inaction. When I first met her online—I hope she will not mind my saying this—she was a physical wreck. She needed assistance to get a visa to the US during the pandemic for urgent medical treatment following a hysteropexy and rectopexy using surgical mesh. A procedure that was intended to resolve her pelvic organ prolapse instead caused devastating harm.

Carol was left with a serious autoimmune disease, struggling to walk and unable to live her daily life. Her prognosis was bleak, and she needed to have the mesh urgently removed. That treatment was not available to her on the NHS. While suffering from chronic pain, and with limited mobility, Carol accessed private treatment in the United States. A combination of determination, medical knowledge and personal resources allowed her to do so, and Carol is now mesh-free following a successful surgery.

Carol attempted to pursue a clinical negligence claim against the surgeons who harmed her, but multiple law firms declined to act because the same surgeons were advising them on other cases. Those conflicts of interest blocked Carol’s access to justice. In one case, the surgeon who caused her life-changing harm acted as an expert witness in an unrelated mesh case. The judge in that case found that the surgeon selectively chose evidence supportive of the defence, failed to provide balanced evidence, and failed in his duty to the court. That finding is on the record.

Such conflicts are not isolated. Conflicts of interest and the closing of ranks among professionals remain a structural barrier to justice for victims. That is just one of the reasons why an independent redress scheme is long overdue. The current system is failing these women, children and families.

I have two questions for the Minister. What conversations are she, her Department and her officials having with the Treasury and Downing Street to make redress a reality for the victims? Will she meet some of the affected families to hear directly from them why redress is so important to them?